About: Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1980

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 1980 (fr) наукова стаття, опублікована в травні 1980 (uk) im Mai 1980 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1980 (ast) scientific article published on 01 May 1980 (en)
publication date	wds:Q72139405-AC6B62DA-1215-45DA-A40E-6CFFF5785C59
publication date	1980-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72139405-587A69AE-C399-466D-AA06-0941F93F5F1A
language of work or name	English
cites work	wds:Q72139405-030B219F-4DE8-4072-BFBA-018A805E8D5A wds:Q72139405-03667FFD-9D7E-4259-B115-D0ADA60335B1 wds:Q72139405-19FA4905-0163-4F6C-A69D-4AFFD558F6E6 wds:Q72139405-3A8D4DA4-7A47-483B-9AAF-28C4474CFECA wds:Q72139405-4C26FC1E-8B41-4922-B240-529F5356FD66 wds:Q72139405-58467DB2-5E0E-45E2-94A9-D31BEABEE018 wds:Q72139405-5BA09F6A-8C93-492E-AACD-22C8EE812A5A wds:Q72139405-64E7C32D-292C-4FFE-894D-29C6F537FED2 wds:Q72139405-7BCAB054-4CFD-4133-93F7-C2690058F4B0 wds:Q72139405-848E7A13-AEAC-4EBC-A7FD-102A23131483 wds:Q72139405-8DCF2DF8-91A9-47E3-82A4-B692DC0B77A6 wds:Q72139405-9900B167-CFC3-4899-B3BA-400317949634 wds:Q72139405-A1B6E430-C1F4-4361-920E-EEE6A54FA9C6 wds:Q72139405-A8798F72-E616-4C59-96AA-F7F1766A3536 wds:Q72139405-C01D636D-DE34-4F5F-AFDE-412629A5F6E7 wds:Q72139405-CEAC56A3-4AD1-4DBD-8B58-6F40F85DA870 wds:Q72139405-E8DD5C38-148C-4DBE-84AC-CB5C748285F1 wds:Q72139405-F23D4B2F-63A3-4E00-A7A6-FFFA6606D6CC wds:Q72139405-F9C72871-F509-460E-8474-EED8C49981E0
cites work	Vitamin E and climacteric syndrome; failure of effective control as measured by menopausal index Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS) Determination of hydroxyproline Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment Bone response to termination of oestrogen treatment The accuracy and reproducibility of bone mineral measurements in vivo'. (b) Methods using sealed isotope sources Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women The prevention of endometrial cancer in postmenopausal women with progestogens Comparative Effects of Oestrogen and a Progestogen on Bone Loss in Postmenopausal Women Prolonged estrogen therapy in postmenopausal women Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women Prospective trial of oestrogen and calcium in postmenopausal women. The accuracy and reproducibility of bone mineral measurements in vivo'. (a) The measurement of metacarpal mineralisation using an x-ray generator Antifracture efficacy of long-term estrogens for osteoporosis Noninvasive measurements of bone mass and their clinical significance Bone loss during oestriol therapy in postmenopausal women The interrelationships between bone mineral at different skeletal sites in male and female cadavera Radiological determination of changes in bone mineral content
author name string	wds:Q72139405-4F4396CB-9A76-47B8-824F-1306776E9A40 wds:Q72139405-DF2FC7EB-EDAF-409E-8F36-436AF7D573F9 wds:Q72139405-F02D3A1C-4FEA-445D-B792-B9035F49811C
author name string	R Lindsay A Kraszewski D M Hart
rdfs:label	Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis (en) Prospective double-blind trial of synthetic steroid (nl)
skos:prefLabel	Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis (en) Prospective double-blind trial of synthetic steroid (nl)
name	Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis (en) Prospective double-blind trial of synthetic steroid (nl)
title	wds:Q72139405-D9835FCA-C69D-435B-8D3A-5694E7B68B37
title	Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis (en)
page(s)	wds:Q72139405-13830E70-C7E1-44A0-8F3F-D28F478DAFD8
page(s)	1207-1209
instance of	wds:Q72139405-8F264C24-0F08-442E-8102-BE6B37D611D0
instance of	scholarly article
main subject	wds:Q72139405-4C7638FA-1324-4CED-A97A-8622E77D2DA7
main subject	postmenopausal osteoporosis
PubMed ID	wds:Q72139405-0F79E1AA-FF35-4F5F-B064-78ED5771147C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6992927
PubMed ID	6992927
published in	wds:Q72139405-D391B2FB-21EC-40FC-9B66-F2854B3C670F
published in	BMJ - General Practice Edition
issue	wds:Q72139405-987A019D-34AE-4B70-B6A4-DCB9E604E639
volume	wds:Q72139405-13979EAF-D94A-4CD7-8D3C-F6E31140EC9B
issue	6225
volume	280
DOI	wds:Q72139405-D27178A2-DBEA-4D45-9AFF-D36D4DE9736E
DOI	http://dx.doi.org/10.1136/BMJ.280.6225.1207
DOI	10.1136/BMJ.280.6225.1207
PMCID	wds:Q72139405-3C32CAC2-9BB2-4B1F-98C4-C5A9B15FAB3F
PMCID	1601498
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72139405
is cites work of	Management of menopause when estrogen cannot be used Differences in serum bone GLA protein with age and sex Health of the nation and osteoporosis Current and potential future drug treatments for osteoporosis New anabolic therapies in osteoporosis The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women. Effect of tibolone on postmenopausal bone loss Hot flashes: aetiology and management Tibolone: a review. Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with Tibolone Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments. Postmenopausal hormone replacement therapy Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Management of established osteoporosis The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software